Journal of Tuberculosis Research, 2016, 4, 1-8
Published Online March 2016 in SciRes. http://www.scirp.org/journal/jtr
http://dx.doi.org/10.4236/jtr.2016.41001
Saudi Journal of Biological Sciences. http://dx.doi.org/10.1016/j.sjbs.2016.03.006
Open Access
Strengthening HIV prevention among most-at-risk populations (MARPs) in the Syrian Arab Republic:
This Technical Brief focuses on current principles and approaches to Moderate Acute Malnutrition (MAM) management, highlighting key constraints, gaps in knowledge and areas still lacking consensus. It is intended to inform ongoing debates among practitioners, national partners, donors and analysts o...n what information and evidence on best practices are currently available, where the gaps are, and priorities for going forward.
more
Over the past 50 years, dengue has spread from nine to over a hundred countries, making it the most rapidly spreading vector-borne disease. Yet, dengue continues to have a low profile among policy-makers and donors and does not receive the media attention it deserves. While there is no vaccine or cu...re for dengue, it can be managed and prevented. We need a renewed commitment to integrated programming that includes improved management and diagnosis, increased awareness and community participation in controlling the vector and enhanced environmental sanitation
more
Interpersonal violence – in all its forms – has a grave effect on children: Violence undermines children’s future potential; damages their physical, psychological and emotional well-being; and in many cases, ends their lives. The report sheds light on the prevalence of different forms of viole...nce against children, with global figures and data from 190 countries. Where relevant, data are disaggregated by age and sex, to provide insights into risk and protective factors.
more
The Open AIDS Journal, 2012, 6, 245-258
Barriers to Full Realization of Human Rights for Women and Children with Disabilities
Mainstreaming Gender in Water and Sanitation
Despite a historical association with poor tolerability, a comprehensive review on safety of antileishmanial chemotherapies is lacking. We carried out an update of a previous systematic review of all published clinical trials in visceral leishmaniasis (VL) from 1980 to 2019 to document any reported ...serious adverse events (SAEs).
more
Principles and Target Product Criteria. Roadmap January 12, 2015
Joint Stakeholder Submission
Accessed: 29.09.2019